Form 4: BlackLine Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
BlackLine director Thomas Unterman reported sales of 7,255 common shares through a pre-arranged Rule 10b5-1 trading plan.
Summary
- Director Thomas Unterman reported the disposition of 7,255 shares of BlackLine, Inc. (BL) common stock.
- The sales occurred across six separate transactions between May 12, 2025, and September 22, 2025, at prices ranging from $55.00 to $56.70 per share.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2024.
- The shares sold were held indirectly through the ETU Rustic Canyon Trust, reducing its beneficial ownership from an initial 50,000 shares to 42,745 shares.
- Thomas Unterman also directly owns 58,636 shares, which were not part of these reported sales.
Sentiment
Score: 5
Explanation: The sales by Director Thomas Unterman were executed under a pre-arranged Rule 10b5-1 trading plan, which mitigates the negative signal typically associated with insider selling. The transactions represent a reduction in indirect beneficial ownership but do not indicate a change in the company's fundamental outlook or performance.
Negatives
- Reduction in Director Thomas Unterman's indirect beneficial ownership of BlackLine common stock by 7,255 shares, from 50,000 shares to 42,745 shares, through the ETU Rustic Canyon Trust.
Future Outlook
The transactions reported are part of a Rule 10b5-1 trading plan adopted on November 21, 2024, which outlines a pre-scheduled program for the sale of equity securities.
Industry Context
Insider trading reports like this Form 4 are routine disclosures in the financial industry, providing transparency into executive and director stock ownership changes. These specific sales by a director of BlackLine, Inc. do not inherently reflect broader industry trends but rather individual financial planning under a pre-arranged trading plan.
Stakeholder Impact
- Shareholders may perceive a slight negative signal from a director reducing their stake, although the existence of a Rule 10b5-1 plan generally lessens this concern as it indicates pre-planned diversification or liquidity needs rather than a reaction to new, undisclosed negative information.
Next Steps
- The Rule 10b5-1 trading plan adopted on November 21, 2024, outlines a pre-scheduled program for the sale of equity securities, implying further transactions may occur according to the plan's terms, though specific future dates beyond those reported are not detailed in this filing.
Key Dates
| Date | Description |
|---|---|
| 11/21/2024 | Rule 10b5-1 trading plan adopted by the reporting person. |
| 05/12/2025 | Sale of 2,730 shares of Common Stock at $55.00. |
| 05/20/2025 | Sale of 910 shares of Common Stock at $55.00. |
| 06/20/2025 | Sale of 910 shares of Common Stock at $55.23. |
| 07/21/2025 | Sale of 885 shares of Common Stock at $56.70. |
| 08/28/2025 | Sale of 910 shares of Common Stock at $55.00. |
| 09/22/2025 | Sale of 910 shares of Common Stock at $55.00. |
| 09/24/2025 | Date of filing of the Statement of Changes in Beneficial Ownership. |
Recommendation
holdThe filing reports routine insider stock sales executed under a pre-arranged Rule 10b5-1 trading plan. Such transactions are typically for personal financial planning, diversification, or liquidity and do not usually signal a change in the company's fundamental prospects. Therefore, this filing alone does not warrant a change in investment recommendation for BlackLine, Inc.
Keywords
BlackLine, BL, Thomas Unterman, SEC Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Director Sales, Equity Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.